vs
GENESIS ENERGY LP（GEL）与Revvity（RVTY）财务数据对比。点击上方公司名可切换其他公司
Revvity的季度营收约是GENESIS ENERGY LP的1.8倍（$772.1M vs $440.8M），Revvity净利率更高（12.7% vs 4.5%，领先8.2%），GENESIS ENERGY LP同比增速更快（10.5% vs 5.9%），Revvity自由现金流更多（$161.8M vs $87.0M），过去两年Revvity的营收复合增速更高（9.0% vs 0.7%）
Genesis Energy LP是一家总部位于美国的中游能源合伙企业，主营原油、天然气、成品油及特种工业原料的基础设施运营与物流服务，旗下资产涵盖管道、仓储码头、海运设施及铁路物流枢纽，为北美地区的炼油厂、工业客户及能源分销商提供服务。
Revvity是一家美国生命科学与诊断领域企业，主要服务制药、生物技术行业客户，重点围绕细胞治疗、基因治疗等前沿技术领域提供相关产品与解决方案，其前身为业务布局多元的老牌企业珀金埃尔默。
GEL vs RVTY — 直观对比
营收规模更大
RVTY
是对方的1.8倍
$440.8M
营收增速更快
GEL
高出4.6%
5.9%
净利率更高
RVTY
高出8.2%
4.5%
自由现金流更多
RVTY
多$74.8M
$87.0M
两年增速更快
RVTY
近两年复合增速
0.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $440.8M | $772.1M |
| 净利润 | $19.9M | $98.4M |
| 毛利率 | — | — |
| 营业利润率 | 20.4% | 14.5% |
| 净利率 | 4.5% | 12.7% |
| 营收同比 | 10.5% | 5.9% |
| 净利润同比 | 140.2% | 3.9% |
| 每股收益（稀释后） | $0.04 | $0.86 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收GELRVTY
| Q4 25 | $440.8M | $772.1M | ||
| Q3 25 | $414.0M | $698.9M | ||
| Q2 25 | $377.3M | $720.3M | ||
| Q1 25 | $398.3M | $664.8M | ||
| Q4 24 | $398.9M | $729.4M | ||
| Q3 24 | $397.3M | $684.0M | ||
| Q2 24 | $430.2M | $691.7M | ||
| Q1 24 | $434.4M | $649.9M |
净利润GELRVTY
| Q4 25 | $19.9M | $98.4M | ||
| Q3 25 | $9.2M | $46.7M | ||
| Q2 25 | $-406.0K | $53.9M | ||
| Q1 25 | $-469.1M | $42.2M | ||
| Q4 24 | $-49.4M | $94.6M | ||
| Q3 24 | $-17.2M | $94.4M | ||
| Q2 24 | $-8.7M | $55.4M | ||
| Q1 24 | $11.4M | $26.0M |
毛利率GELRVTY
| Q4 25 | — | — | ||
| Q3 25 | — | 53.6% | ||
| Q2 25 | — | 54.5% | ||
| Q1 25 | — | 56.5% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 56.3% | ||
| Q2 24 | — | 55.7% | ||
| Q1 24 | — | 54.6% |
营业利润率GELRVTY
| Q4 25 | 20.4% | 14.5% | ||
| Q3 25 | 19.0% | 11.7% | ||
| Q2 25 | 17.9% | 12.6% | ||
| Q1 25 | 5.5% | 10.9% | ||
| Q4 24 | 3.4% | 16.3% | ||
| Q3 24 | 12.2% | 14.3% | ||
| Q2 24 | 11.6% | 12.4% | ||
| Q1 24 | 13.4% | 6.8% |
净利率GELRVTY
| Q4 25 | 4.5% | 12.7% | ||
| Q3 25 | 2.2% | 6.7% | ||
| Q2 25 | -0.1% | 7.5% | ||
| Q1 25 | -117.8% | 6.4% | ||
| Q4 24 | -12.4% | 13.0% | ||
| Q3 24 | -4.3% | 13.8% | ||
| Q2 24 | -2.0% | 8.0% | ||
| Q1 24 | 2.6% | 4.0% |
每股收益（稀释后）GELRVTY
| Q4 25 | $0.04 | $0.86 | ||
| Q3 25 | $-0.05 | $0.40 | ||
| Q2 25 | $-0.12 | $0.46 | ||
| Q1 25 | $-4.06 | $0.35 | ||
| Q4 24 | $-0.58 | $0.77 | ||
| Q3 24 | $-0.32 | $0.77 | ||
| Q2 24 | $-0.25 | $0.45 | ||
| Q1 24 | $-0.09 | $0.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $6.4M | $919.9M |
| 总债务越低越好 | $3.0B | — |
| 股东权益账面价值 | — | $7.3B |
| 总资产 | $4.9B | $12.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资GELRVTY
| Q4 25 | $6.4M | $919.9M | ||
| Q3 25 | $4.9M | $931.4M | ||
| Q2 25 | $4.5M | $991.8M | ||
| Q1 25 | $377.4M | $1.1B | ||
| Q4 24 | $7.4M | $1.2B | ||
| Q3 24 | $13.0M | $1.2B | ||
| Q2 24 | $13.7M | $2.0B | ||
| Q1 24 | $7.0M | $1.7B |
总债务GELRVTY
| Q4 25 | $3.0B | — | ||
| Q3 25 | $3.1B | — | ||
| Q2 25 | $3.1B | — | ||
| Q1 25 | $3.4B | — | ||
| Q4 24 | $3.7B | — | ||
| Q3 24 | $4.0B | — | ||
| Q2 24 | $3.9B | — | ||
| Q1 24 | $3.8B | — |
股东权益GELRVTY
| Q4 25 | — | $7.3B | ||
| Q3 25 | — | $7.4B | ||
| Q2 25 | — | $7.6B | ||
| Q1 25 | — | $7.6B | ||
| Q4 24 | — | $7.7B | ||
| Q3 24 | — | $7.9B | ||
| Q2 24 | — | $7.9B | ||
| Q1 24 | — | $7.8B |
总资产GELRVTY
| Q4 25 | $4.9B | $12.2B | ||
| Q3 25 | $4.9B | $12.1B | ||
| Q2 25 | $4.8B | $12.4B | ||
| Q1 25 | $5.2B | $12.4B | ||
| Q4 24 | $7.0B | $12.4B | ||
| Q3 24 | $7.1B | $12.8B | ||
| Q2 24 | $7.0B | $13.4B | ||
| Q1 24 | $6.9B | $13.4B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $110.8M | $182.0M |
| 自由现金流经营现金流 - 资本支出 | $87.0M | $161.8M |
| 自由现金流率自由现金流/营收 | 19.7% | 21.0% |
| 资本支出强度资本支出/营收 | 5.4% | 2.6% |
| 现金转化率经营现金流/净利润 | 5.58× | 1.85× |
| 过去12个月自由现金流最近4个季度 | $65.9M | $509.4M |
8季度趋势，按日历期对齐
经营现金流GELRVTY
| Q4 25 | $110.8M | $182.0M | ||
| Q3 25 | $70.3M | $138.5M | ||
| Q2 25 | $47.0M | $134.3M | ||
| Q1 25 | $24.8M | $128.2M | ||
| Q4 24 | $74.0M | $174.2M | ||
| Q3 24 | $87.3M | $147.9M | ||
| Q2 24 | $104.7M | $158.6M | ||
| Q1 24 | $125.9M | $147.6M |
自由现金流GELRVTY
| Q4 25 | $87.0M | $161.8M | ||
| Q3 25 | $43.3M | $120.0M | ||
| Q2 25 | $-7.6M | $115.5M | ||
| Q1 25 | $-56.8M | $112.2M | ||
| Q4 24 | $-47.1M | $149.8M | ||
| Q3 24 | $-32.3M | $125.6M | ||
| Q2 24 | $-67.5M | $136.6M | ||
| Q1 24 | $-48.3M | $129.7M |
自由现金流率GELRVTY
| Q4 25 | 19.7% | 21.0% | ||
| Q3 25 | 10.5% | 17.2% | ||
| Q2 25 | -2.0% | 16.0% | ||
| Q1 25 | -14.3% | 16.9% | ||
| Q4 24 | -11.8% | 20.5% | ||
| Q3 24 | -8.1% | 18.4% | ||
| Q2 24 | -15.7% | 19.7% | ||
| Q1 24 | -11.1% | 20.0% |
资本支出强度GELRVTY
| Q4 25 | 5.4% | 2.6% | ||
| Q3 25 | 6.5% | 2.6% | ||
| Q2 25 | 14.5% | 2.6% | ||
| Q1 25 | 20.5% | 2.4% | ||
| Q4 24 | 30.3% | 3.4% | ||
| Q3 24 | 30.1% | 3.3% | ||
| Q2 24 | 40.0% | 3.2% | ||
| Q1 24 | 40.1% | 2.7% |
现金转化率GELRVTY
| Q4 25 | 5.58× | 1.85× | ||
| Q3 25 | 7.63× | 2.97× | ||
| Q2 25 | — | 2.49× | ||
| Q1 25 | — | 3.03× | ||
| Q4 24 | — | 1.84× | ||
| Q3 24 | — | 1.57× | ||
| Q2 24 | — | 2.87× | ||
| Q1 24 | 11.09× | 5.67× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
GEL
| Onshore Facilities And Transportation Revenue | $204.2M | 46% |
| Offshore Pipeline Transportation Revenue | $154.3M | 35% |
| Marine Transportation Revenue | $82.2M | 19% |
RVTY
| Immunodiagnostics | $240.8M | 31% |
| Life Sciences | $191.4M | 25% |
| Reproductive Health | $149.3M | 19% |
| Segment Operating Income | $132.0M | 17% |
| Software | $62.3M | 8% |
